Home » Topics » BioWorld Science

BioWorld Science
RSS

New muscarinic M1 receptor antagonists presented by Pipeline Therapeutics

Jan. 3, 2020

Chemrar Research & Development Institute discloses dopamine D2 and D3 receptor agonists

Jan. 3, 2020

BioTheryX presents new compounds for cancer

Jan. 3, 2020

Chiesi Farmaceutici identifies ROCK1 and ROCK2 inhibitors

Jan. 3, 2020

Cadila Healthcare divulges new antimycobacterial compounds

Jan. 3, 2020

Celgene presents first-in-human data for CC-90009

Jan. 3, 2020

JNJ-7706621 reverses resistance to CD37-targeted radioimmunotherapy in DLBCL

Jan. 3, 2020

ZBP1 as a new therapeutic target in multiple myeloma

Jan. 3, 2020

Viral infection may be second hit for familial ALS

Jan. 3, 2020

PPARgamma controls antifibrotic network

Jan. 3, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...